BRKR

Bruker Corporation
NASDAQHEALTHCAREMEDICAL DEVICES

Key Statistics

Market Cap
$8.35B
P/E Ratio
—
EPS
$-0.70
Beta
1.22
52W High
$66.98
52W Low
$32.27
50-Day MA
$58.69
200-Day MA
$49.85
Dividend Yield
0.35%
Profit Margin
-2.04%
Forward P/E
13.83
PEG Ratio
1.52

About Bruker Corporation

Bruker Corporation develops, manufactures and distributes scientific instruments and analytical and diagnostic solutions in the United States, Europe, Asia Pacific, and internationally. The company is headquartered in Billerica, Massachusetts.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$3.50B
Gross Profit (TTM)$1.70B
EBITDA$541.10M
Operating Margin9.88%
Return on Equity-3.00%
Return on Assets3.14%
Revenue/Share (TTM)$23.01
Book Value$15.63
Price-to-Book3.82
Price-to-Sales (TTM)2.39
EV/Revenue3.055
EV/EBITDA39.72
Quarterly Earnings Growth (YoY)-81.80%
Quarterly Revenue Growth (YoY)5.20%
Shares Outstanding$152.36M
Float$103.69M
% Insiders26.97%
% Institutions95.77%

Historical Volatility

HV 10-Day
40.00%
HV 20-Day
45.68%
HV 30-Day
54.64%
HV 60-Day
71.73%
HV Rank
58.3%

Volatility is currently contracting

Analyst Ratings

Consensus ($63.83 target)
2
Strong Buy
5
Buy
5
Hold
1
Sell

Latest News

Untargeted timsTOF Mass Spectrometry Enables Discovery and Mapping of Draft Atlas of the Human Plasma Proteome at Proteoform Resolution

BERLIN--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) announced a seminal bioRxiv preprint, describing a draft atlas of the human plasma proteome at isoform, or proteoform, resolution. The study was conducted by principal investigator Markus Ralser at Charité – Universitätsmedizin Berlin and collaborators. The preprint “A draft atlas of the human plasma proteome at isoform resolution” was posted on September 28, 2026 at https://doi.org/10.64898/2026.09.26.754256. By combining intact protei.

Business Wire10/6/2026Neutral
Bruker Advances Functional Proteomics with Novel timsUltra AIP and timsOmni Workflows for Drug Discovery & Development and Disease Biology Research

SINGAPORE--(BUSINESS WIRE)---- $BRKR #BRKR--At the Human Proteome Organization World Congress 2026, Bruker Corporation (Nasdaq: BRKR) today announced unique new timsUltra AIP and timsOmni workflows for deeper protein-sequence coverage, targeted validation, mobility-resolved glycopeptide characterization, structural proteomics, and oligonucleotide analysis. Multi-enzyme dia-PASEF provides additional peptide information for investigations of isoforms and proteoforms, while ProteoScape workflows connect PASEF dis.

Business Wire9/28/2026Neutral
Bruker Receives Order for High-Field NMR Systems for Major Upgrade of Magnetic Resonance Research Infrastructure at UC Berkeley

BERKELEY, Calif.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced a multi-system order from the University of California, Berkeley for high-field Nuclear Magnetic Resonance (NMR) instrumentation at the Pines Magnetic Resonance Center. The investment will enhance access to next-generation NMR technologies, including 800 MHz–class instrumentation. These capabilities strengthen research in chemistry, materials science, structural biology, and related fields across UC Berkeley an.

Business Wire9/21/2026Neutral
Bruker Corporation to Present at Upcoming Investor Conferences

BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) announced today that its senior leadership will present at the following conferences: Wells Fargo 21st Annual Healthcare Conference in Boston, MA Wednesday, September 9, 2026 at 8:00 a.m. Eastern Time Morgan Stanley 24th Annual Global Healthcare Conference in New York City Wednesday, September 16, 2026, at 10:45 a.m. Eastern Time Bank of America Global Healthcare Conference in London, UK Tuesday, September 22, 2026, at 6:45 a.

Business Wire9/8/2026Neutral
BEST and Luvata Announce Collaboration Agreement for Supply of High-Performance RRP® Superconductors for Magnetic Confinement Fusion

HANAU, Germany--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Energy & Supercon Technologies (BEST), a segment of Bruker Corporation (Nasdaq: BRKR), and Luvata Materials & Solutions, a Business Unit of Luvata Group (LUVATA) today announced a strategic collaboration to support the rapidly growing demand for superconducting materials and technologies required by next-generation magnetic confinement fusion power demonstration plant projects worldwide.The BEST-LUVATA collaboration aims to further strengthen and e.

Business Wire9/4/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on BRKR and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 10/17/2026